Try our mobile app

Switch to company model in classical logic    *

General information

Country: INDIA

Sector: Drug Manufacturers — Specialty and Generic

Dr. Reddy`s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy`s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation...
Website: drreddys.com



Growth: Good revenue growth rate 16.6%, there is slowdown compared to average historical growth rates 20.2%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -24.0%

Profitability: LTM EBITDA margin is positive, +28.5%. On average the margin is decreasing unsteadily. Gross margin is high, +59.6%. In the last quarter the company beat the estimated EPS, +9.4%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.1 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.8%. Free cash flow yield -17.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 2.3% higher than minimum and 86.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.7x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: RDY
Share price, USD:  (-0.1%)11.79
year average price 13.87  


year start price 14.67 2025-07-26

max close price 15.38 2026-06-27

min close price 11.52 2026-07-22

current price 11.79 2026-07-25
Common stocks: 166 786 484

Dividend Yield:  0.8%
FCF Yield LTM: -17.2%
EV / LTM EBITDA: 2.5x
EV / EBITDA annualized: 2.3x
Last revenue growth (y/y):  +16.6%
Last growth of EBITDA (y/y):  +8.6%
Historical revenue growth:  +20.2%
Historical growth of EBITDA:  +41.4%
EV / Sales: 0.7x
Margin (EBITDA LTM / Revenue): 28.5%
Fundamental value created in LTM:
Market Cap ($m): 1 968
Net Debt ($m): 411
EV (Enterprise Value): 2 379
Price to Book: 0.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-22zacks.com

Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y

2026-01-21seekingalpha.com

Dr. Reddy's Laboratories Limited (RDY) Q3 2026 Earnings Call Transcript

2025-08-18globenewswire.com

Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

2025-07-23businesswire.com

Dr. Reddy's Q1FY26 Financial Results

2025-05-15seekingalpha.com

Dr. Reddy's Continues To Be A Good Buy At Current Valuation

2025-05-12youtube.com

Generics won't be affected by Trump's pricing policy, says Dr. Reddy's

2025-05-09seekingalpha.com

Dr. Reddy's Laboratories Limited (RDY) Q4 2025 Earnings Call Transcript

2025-03-27prnewswire.com

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

2025-03-19zacks.com

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

2025-01-24zacks.com

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10 2022-03-31 2021-03-31
symbol RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR INR INR INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-24 2025-06-30 2024-09-30 2024-06-12 2024-06-12 2023-09-30 2023-06-30 2022-12-31 2022-09-12
acceptedDate 2025-10-24 11:10:25 2025-06-30 00:00:00 2025-06-06 17:19:05 2024-09-30 00:00:00 2024-06-12 17:05:01 2024-06-12 17:05:01 2024-06-12 17:05:01 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46 2022-06-27 15:02:33 2021-06-30 11:51:32
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 88 051M 85 452M 325 535M 80 162M 76 727M 279 164M 72 148M 68 802M 67 384M 245 879M 67 700M 63 057M 214 391M 2 556M
costOfRevenue 39 911M 36 825M 135 107M 32 393M 30 383M 115 557M 29 945M 28 434M 27 831M 106 536M 27 607M 25 810M 100 551M 1 258M
grossProfit 48 140M 48 627M 190 428M 47 769M 46 344M 163 607M 42 203M 40 368M 39 553M 139 343M 40 093M 37 247M 113 840M 1 298M
grossProfitRatio 0.547 0.569 0.596 0.604 0.585 0.587 0.587 0.592 0.591
researchAndDevelopmentExpenses 6 202M 6 244M 27 380M 7 271M 6 193M 22 873M 5 565M 5 447M 4 984M 19 381M 4 821M 4 869M 17 482M 208M
generalAndAdministrativeExpenses 0 23 181M 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 26 436M 23 181M 93 870M 23 007M 22 691M 77 201M 20 228M 18 795M 17 702M 68 026M 17 981M 16 560M 62 081M 660M
otherExpenses -2 011M 1 727M -2 665M -60M -465M -4 196M 0 0 0 -5 208M 800M -423M 4 801M 2M
operatingExpenses 30 627M 31 152M 118 585M 30 218M 28 419M 95 878M 25 297M 22 883M 21 906M 82 199M 23 602M 21 006M 84 364M 866M
costAndExpenses 70 538M 67 977M 253 692M 62 611M 58 802M 211 435M 55 242M 51 317M 49 737M 188 735M 51 209M 46 816M 184 915M 2 124M
interestIncome 1 681M 1 128M 2 677M 665M 0 2 278M 583M 719M 329M 1 180M 2 695M 216M 965M 826M
interestExpense 907M 830M 2 829M 757M 0 1 711M 394M 353M 371M 1 428M 419M 309M 958M 970M
depreciationAndAmortization 5 051M 4 765M 17 058M 3 975M 3 810M 14 841M 3 770M 3 789M 22M 12 636M 2 822M 3 596M 11 824M 172M
ebitda 24 308M 24 642M 96 671M 23 899M 21 757M 88 422M 21 286M 22 035M 17 658M 74 431M 19 247M 19 723M 45 080M 535M
ebitdaratio 0.276 0.288 0.298 0.284 0.295 0.32 0.262 0.284 0.313
operatingIncome 17 513M 17 475M 71 843M 17 551M 17 925M 67 729M 17 267M 17 867M 17 636M 57 144M 16 425M 16 127M 29 476M 431M
operatingIncomeRatio 0.199 0.205 0.219 0.234 0.239 0.26 0.262 0.243 0.256
totalOtherIncomeExpensesNet 837M 1 572M 4 941M 1 616M 896M 4 141M 1 162M 1 283M 32M 3 223M -79M -16M 2 822M -76M
incomeBeforeTax 18 350M 19 047M 76 784M 19 167M 18 821M 71 870M 18 257M 19 134M 18 463M 60 367M 16 346M 16 111M 32 298M 356M
incomeBeforeTaxRatio 0.208 0.223 0.239 0.245 0.253 0.278 0.274 0.241 0.255
incomeTaxExpense 4 082M 4 951M 19 539M 5 752M 4 901M 16 186M 4 468M 4 334M 4 438M 15 300M 3 875M 4 983M 8 730M 124M
netIncome 14 372M 14 178M 56 544M 12 553M 13 920M 55 684M 13 789M 14 800M 14 025M 45 067M 12 471M 11 128M 23 568M 232M
netIncomeRatio 0.163 0.166 0.157 0.181 0.191 0.215 0.208 0.184 0.176
eps 17.27 17.04 67.85 0 83.46 66.8 82.81 88.96 84.21 54.29 75.53 67.4 28.42 20.79
epsdiluted 17.25 17.02 0 83.46 82.68 88.78 84.21 74.96 66.89
weightedAverageShsOut 832M 832M 833M 0 167M 834M 167M 166M 167M 830M 165M 165M 829M 829M
weightedAverageShsOutDil 833M 833M 834M 0 167M 834M 167M 167M 167M 832M 166M 166M 832M 832M
link Link Link Link Link
finalLink Link Link Link Link
filingDate 2025-06-06 2024-06-12 2023-06-13 2022-06-27 2021-06-30
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -152M 567M -248M 7M -144M
ebit 79 613M 73 581M 61 795M 33 256M 362M
nonOperatingIncomeExcludingInterest -7 770M -5 852M -4 651M -3 780M 69M
netIncomeFromContinuingOperations 57 245M 55 684M 45 067M 23 568M 232M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 1
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 56 544M 55 684M 45 067M 23 568M 232M
epsDiluted 67.77 66.8 54.17 28.34 20.73

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10 2022-03-31 2021-03-31
symbol RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR INR INR INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-24 2025-06-30 2024-09-30 2024-06-12 2024-06-12 2023-09-30 2023-06-30 2022-12-31 2022-09-12
acceptedDate 2025-10-24 11:10:25 2025-06-30 00:00:00 2025-06-06 17:19:05 2024-09-30 00:00:00 2024-06-12 17:05:01 2024-06-12 17:05:01 2024-06-12 17:05:01 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46 2022-06-27 15:02:33 2021-06-30 11:51:32
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 9 906M 9 004M 14 654M 11 330M 4 913M 7 107M 7 342M 13 391M 6 017M 5 779M 6 259M 9 096M 14 852M 203M
shortTermInvestments 59 905M 57 684M 43 254M 51 744M 89 713M 74 363M 65 015M 54 390M 53 032M 56 018M 42 241M 18 479M 29 513M 270M
cashAndShortTermInvestments 69 811M 66 688M 57 908M 63 074M 94 626M 81 470M 72 357M 67 781M 61 162M 61 797M 50 164M 27 575M 44 365M 473M
netReceivables 120 841M 115 443M 109 792M 102 840M 81 088M 95 338M 96 078M 89 693M 77 248M 83 203M 77 338M 80 052M 80 270M 844M
inventory 75 821M 75 600M 71 085M 72 039M 68 568M 63 552M 60 796M 56 592M 52 398M 48 670M 49 326M 49 042M 50 884M 621M
otherCurrentAssets 13 044M 12 167M 4 559M 10 175M 24 906M 2 940M 4 215M 1 000 000 18 512M 6 407M 19 142M 18 329M 5 199M 74M
totalCurrentAssets 279 517M 269 898M 250 112M 248 128M 269 188M 248 049M 238 477M 217 695M 113 560M 204 253M 49 326M 175 606M 181 856M 2 028M
propertyPlantEquipmentNet 111 981M 102 784M 97 761M 86 693M 80 343M 76 886M 72 795M 70 478M 67 207M 66 462M 64 996M 63 817M 62 169M 781M
goodwill 12 298M 11 975M 11 810M 11 773M 4 243M 4 253M 4 287M 4 223M 4 238M 4 245M 4 495M 4 328M 4 418M 62M
intangibleAssets 100 942M 95 597M 96 803M 92 119M 37 131M 36 951M 36 905M 37 055M 38 068M 30 849M 30 906M 31 756M 27 246M 488M
goodwillAndIntangibleAssets 113 240M 107 572M 108 613M 103 892M 41 374M 41 204M 41 192M 41 278M 42 306M 35 094M 35 401M 36 084M 31 664M 550M
longTermInvestments 9 765M 11 419M 15 202M 5 979M 5 209M 5 255M 8 333M 5 924M 4 904M 5 362M 6 279M 6 107M 7 986M 116M
taxAssets 22 717M 24 197M 18 508M 17 475M 0 10 774M 10 917M 10 835M 9 544M 7 196M 6 306M 7 559M 8 204M 145M
otherNonCurrentAssets 4 785M 3 667M 2 793M 3 788M 19 183M 5 350M 1 128M 812M -14 448M 3 487M -12 585M 1 801M 948M 11M
totalNonCurrentAssets 262 488M 249 639M 242 877M 217 827M 146 109M 139 469M 134 365M 129 327M 109 513M 117 601M 100 397M 115 368M 110 971M 1 604M
otherAssets 0 0 0 0 0 0 0 0 111 967M 0 159 577M 0 0 0
totalAssets 542 005M 519 537M 492 989M 465 955M 415 297M 387 518M 372 842M 347 022M 335 040M 321 854M 309 300M 290 974M 292 827M 3 631M
accountPayables 40 248M 37 457M 20 053M 35 776M 34 109M 21 547M 31 113M 30 485M 55 364M 17 857M 26 023M 22 778M 15 971M 174M
shortTermDebt 46 902M 43 548M 38 045M 41 179M 24 446M 12 723M 13 699M 7 187M 7 590M 11 190M 16 206M 15 494M 27 082M 328M
taxPayables 7 628M 10 521M 3 028M 5 089M 4 858M 2 342M 4 174M 3 985M 4 432M 2 144M 1 333M 1 257M 1 615M 19M
deferredRevenue 2 065M 1 834M 1 983M 1 530M 10 329M 1 435M 2 269M 3 001M 47 774M 1 981M 0 0 2 576M 28M
otherCurrentLiabilities 54 084M 49 231M 13 523M 45 725M 21 602M 11 417M 46 519M 43 510M -55 364M 9 193M -16 206M 41 759M 6 761M 515M
totalCurrentLiabilities 150 927M 142 591M 130 392M 129 299M 105 673M 96 039M 93 600M 84 183M 55 364M 85 845M 26 023M 80 031M 94 015M 1 141M
longTermDebt 11 637M 5 096M 3 800M 7 361M 6 229M 3 800M 6 152M 6 043M 4 930M 0 1 457M 1 795M 3 800M 52M
deferredRevenueNonCurrent 1 307M 1 152M 1 162M 999M 61M 1 193M 1 444M 1 497M 60M 1 555M 0 0 1 597M 21M
deferredTaxLiabilitiesNonCurrent 14 827M 14 450M 14 108M 13 830M -61M 909M 989M 102M 642M 833M 160M 46M 60M 5M
otherNonCurrentLiabilities 1 225M 2 493M 2 297M 5 183M 8 707M 2 837M 2 807M 2 111M 3 382M 1 352M 24 406M -33 554M 882M 12M
totalNonCurrentLiabilities 28 996M 23 191M 25 431M 27 373M 14 997M 10 929M 11 392M 9 753M 9 014M 5 018M 26 023M 4 718M 8 285M 124M
otherLiabilities 0 0 0 0 0 0 0 0 -9 014M 0 0 0 0 0
capitalLeaseObligations 13 584M 6 463M 4 921M 4 719M 3 710M 3 497M 3 708M 3 579M 2 252M 2 282M 2 395M 2 716M 2 963M 34M
totalLiabilities 179 923M 165 782M 155 823M 156 672M 120 670M 106 968M 104 992M 93 936M 55 364M 90 863M 52 046M 84 749M 102 300M 1 264M
preferredStock 0 0 0 0 4 111M 0 0 0 0 0 0 0 0 0
commonStock 835M 835M 834M 834M 834M 834M 834M 834M 833M 833M 833M 832M 832M 11M
retainedEarnings 337 683M 329 971M 315 793M 285 180M 279 830M 265 257M 252 078M 238 226M 230 020M 215 593M 206 714M 194 165M 175 712M 2 134M
accumulatedOtherComprehensiveIncomeLoss 3 979M 3 979M 3 979M 4 520M 4 111M 653M 762M 810M 864M 886M 553M 631M 755M 127M
othertotalStockholdersEquity 15 992M 15 274M 14 810M 1 630M 14 176M 13 216M 13 542M 12 173M 10 597M
totalStockholdersEquity 358 489M 350 059M 333 388M 305 344M 294 627M 280 550M 267 850M 253 086M 245 259M 230 991M 220 273M 206 225M 190 527M 2 367M
totalEquity 362 082M 353 755M 337 166M 309 283M 294 627M 280 550M 267 850M 253 086M 245 259M 230 991M 220 273M 206 225M 190 527M 2 367M
totalLiabilitiesAndStockholdersEquity 542 005M 519 537M 465 955M 415 297M 372 842M 347 022M 335 040M 309 300M 290 974M
minorityInterest 3 593M 3 696M 3 778M 3 939M 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 542 005M 519 537M 492 989M 465 955M 415 297M 387 518M 372 842M 347 022M 335 040M 321 854M 309 300M 290 974M 292 827M 3 631M
totalInvestments 69 670M 69 103M 58 456M 57 723M 94 922M 79 618M 73 348M 60 314M 57 936M 61 380M 48 520M 24 586M 37 499M 386M
totalDebt 58 539M 48 644M 46 766M 48 540M 30 675M 20 020M 19 851M 13 230M 12 520M 13 472M 17 663M 17 289M 33 845M 415M
netDebt 48 633M 39 640M 32 112M 37 210M 25 762M 12 913M 12 509M -161M 6 503M 7 693M 11 404M 8 193M 18 993M 212M
link Link Link Link Link
finalLink Link Link Link Link
filingDate 2025-06-06 2024-06-12 2023-06-13 2022-06-27 2021-06-30
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 90 420M 80 298M 72 485M 66 764M 679M
otherReceivables 19 372M 15 040M 10 718M 13 506M 165M
prepaids 6 768M 4 749M 4 176M 1 138M 16M
totalPayables 50 849M 44 374M 40 633M 36 524M 193M
otherPayables 30 796M 22 827M 22 776M 20 553M 19M
accruedExpenses 25 135M 24 783M 21 844M 20 055M 77M
capitalLeaseObligationsCurrent 857M 1 307M 1 004M 1 017M 0
capitalLeaseObligationsNonCurrent 4 064M 2 190M 1 278M 1 946M 34M
treasuryStock -2 264M -991M -1 269M -1 601M -27M
additionalPaidInCapital 11 306M 10 938M 10 241M 9 757M 122M
otherTotalStockholdersEquity 3 740M 3 859M 4 707M 5 072M 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10 2022-03-31 2021-03-31
symbol RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR INR INR INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-24 2025-06-30 2024-09-30 2024-06-12 2024-06-12 2023-09-30 2023-06-30 2022-12-31 2022-09-12
acceptedDate 2025-10-24 11:10:25 2025-06-30 00:00:00 2025-06-06 17:19:05 2024-09-30 00:00:00 2024-06-12 17:05:01 2024-06-12 17:05:01 2024-06-12 17:05:01 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46 2022-06-27 15:02:33 2021-06-30 11:51:32
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 14 268M 14 096M 57 245M 13 415M 13 920M 55 684M 13 789M 14 800M 14 025M 45 067M 12 471M 11 128M 23 568M 17 238M
depreciationAndAmortization 5 051M 4 765M 17 058M 3 975M 3 810M 14 841M 3 770M 3 789M 3 569M 12 636M 3 271M 3 126M 11 824M 12 796M
deferredIncomeTax 4 082M 4 951M 19 539M 5 752M 4 901M 16 186M 4 468M 4 334M 4 438M 15 300M 3 875M 4 983M 8 730M 9 175M
stockBasedCompensation 100M 112M 424M 107M 101M 407M 99M 103M 108M 397M 113M 117M 592M 584M
changeInWorkingCapital -2 556M -8 191M -29 989M -7 784M -13 141M -20 182M -11 855M 2 609M -8 174M -7 855M 6 024M -9 784M -13 914M -10 718M
accountsReceivables -2 882M -4 807M -10 283M -3 396M -786M -8 054M -8 826M 7 336M 0 -5 752M 0 0 -17 012M 2 081M
inventory -2 036M -6 150M -12 753M -5 008M -6 323M -18 445M -5 203M -4 702M -4 638M -2 654M -284M 2 768M -5 328M -12 402M
accountsPayables 0 0 0 0 0 0 8 826M -7 336M 0 0 0 0 17 012M 0
otherWorkingCapital 2 362M 2 766M -6 953M 620M -6 032M 6 317M -6 652M 7 311M -3 536M 551M 6 308M -12 552M -8 586M -397M
otherNonCashItems -5 372M -1 104M -17 849M -6 149M -1 095M -21 503M -5 534M -7 709M -2 716M -6 670M -2 494M -289M -2 692M 6 628M
netCashProvidedByOperatingActivities 15 573M 14 629M 46 428M 9 316M 8 496M 45 433M 4 737M 17 926M 11 250M 58 875M 23 260M 9 281M 28 108M 35 703M
investmentsInPropertyPlantAndEquipment -5 223M -6 861M -27 504M -7 536M -5 110M -16 403M -5 042M -3 939M -12 171M -11 323M -3 099M -3 329M -19 049M -9 741M
acquisitionsNet 0 -51M -53 413M 0 0 -12M 5 042M 3 939M 12 171M 0 0 0 -326M -15 514M
purchasesOfInvestments -51 231M -51 600M -254 458M -76 590M -61 736M -145 488M -35 166M -40 399M -29 609M -136 171M -40 699M -19 871M -88 972M -75 418M
salesMaturitiesOfInvestments 51 550M 41 739M 279 576M 115 722M 47 266M 129 784M 23 203M 38 651M 33 164M 112 805M 17 219M 28 753M 77 771M 79 528M
otherInvestingActivites -4 639M -2 419M -50 667M -668M -4 217M -2 769M -11 791M 169M 180M
netCashUsedForInvestingActivites -9 543M -19 192M -19 071M -20 248M -16 180M -4 517M -8 236M -26 410M 5 733M
debtRepayment 2 366M -256M 16 555M 10 266M -697M -587M -4 791M -1 094M -17 082M
commonStockIssued 92M 196M 7 194M 19M 9M 686M 79M 81M 35M
commonStockRepurchased 0 0 -1 389M 0 0 0 0 0 0 0 0 0 0 -1 193M
dividendsPaid -6 659M 0 -6 662M 0 0 -6 648M 0 0 -4 979M
otherFinancingActivites -1 122M -1 143M -937M -744M 5 970M -487M 3 236M 1 596M 9 680M
netCashUsedProvidedByFinancingActivities -5 323M -1 203M 16 150M 9 541M 5 282M -7 036M -1 476M 583M -12 346M
effectOfForexChangesOnCash 195M 177M 224M -23M 17M -59M 161M -66M -89M 286M -267M 128M 733M 113M
netChangeInCash 902M -5 589M 7 486M 6 372M -2 194M 1 328M -6 000M 6 307M 1 449M -9 073M -2 834M 2 796M 32M 12 858M
cashAtEndOfPeriod 9 906M 9 004M 14 593M 11 285M 4 913M 7 107M 7 535M 13 535M 7 228M 5 779M 6 259M 9 093M 14 852M 14 820M
cashAtBeginningOfPeriod 9 004M 14 593M 7 107M 4 913M 7 107M 5 779M 13 535M 7 228M 5 779M 14 852M 9 093M 6 297M 14 820M 1 962M
operatingCashFlow 15 573M 14 629M 46 428M 9 316M 8 496M 45 433M 4 737M 17 926M 11 250M 58 875M 23 260M 9 281M 28 108M 35 703M
capitalExpenditure -10 135M -10 147M -34 398M -7 909M -6 424M -27 435M -5 042M -3 939M -12 171M -18 866M -3 099M -3 329M -19 049M -12 561M
freeCashFlow 5 438M 4 482M 12 030M 1 407M 2 072M 17 998M -305M 13 987M -921M 40 009M 20 161M 5 952M 9 059M 23 142M
link Link Link Link Link
finalLink Link Link Link Link
filingDate 2025-06-06 2024-06-12 2023-06-13 2022-06-27 2021-06-30
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -2 278M -8 164M -6 684M 4 189M -1 515M
netCashProvidedByInvestingActivities -58 077M -40 283M -41 373M -26 387M -22 660M
netDebtIssuance 23 196M 4 346M -20 397M 2 735M 6 094M
longTermNetDebtIssuance -1 294M -1 147M -1 015M -785M -697M
shortTermNetDebtIssuance 24 490M 5 493M -19 382M 3 520M 6 791M
netStockIssuance -1 196M 805M 368M 334M -924M
netCommonStockIssuance -1 196M 805M 368M 334M -924M
commonStockIssuance 193M 805M 368M 334M 269M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -6 662M -6 648M -4 979M -4 146M -4 147M
commonDividendsPaid -6 662M -6 648M -4 979M -4 146M -4 147M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 3 573M -2 266M -1 853M -1 345M -1 321M
netCashProvidedByFinancingActivities 18 911M -3 763M -26 861M -2 422M -298M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q4
2026-01-21 ET (fiscal 2026 q3)
2025 q3
2025-10-24 ET (fiscal 2026 q2)
2025 q2
2025-07-23 ET (fiscal 2026 q1)
2025 q1
2025-05-09 ET (fiscal 2025 q4)
2024 q4
2025-01-23 ET (fiscal 2025 q3)
2024 q3
2024-11-05 ET (fiscal 2025 q2)
2024 q2
2024-07-27 ET (fiscal 2025 q1)
2024 q1
2024-05-07 ET (fiscal 2024 q4)
2023 q4
2024-01-30 ET (fiscal 2024 q3)
2023 q3
2023-10-27 ET (fiscal 2024 q2)
2023 q2
2023-07-26 ET (fiscal 2024 q1)
2023 q1
2023-05-11 ET (fiscal 2023 q4)
2022 q4
2023-01-25 ET (fiscal 2023 q3)
2022 q3
2022-10-28 ET (fiscal 2023 q2)
2022 q2
2022-07-31 ET (fiscal 2023 q1)
2022 q1
2022-05-19 ET (fiscal 2022 q4)
2021 q4
2022-01-28 ET (fiscal 2022 q3)

Press-releases

Show financial reports only

2026-06-26 ET
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
2026-06-13 ET
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
2026-05-16 ET
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
2026-04-29 11:38 ET
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
2026-02-20 ET
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
2026-01-14 ET
Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.
2025-12-02 ET
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
2025-10-22 ET
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
2025-08-25 ET
Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
2025-07-23 ET
Dr. Reddy’s Q1FY26 Financial Results
2025-06-05 ET
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
2025-05-09 ET
Dr. Reddy’s Q4 & Full Year FY25 Financial Results
2025-03-27 ET
Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
2025-03-18 ET
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
2025-03-18 ET
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
2025-03-13 ET
Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
2025-02-06 ET
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
2025-02-06 ET
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
2025-01-23 ET
Dr. Reddy’s Q3 & 9MFY25 Financial Results
2024-11-28 ET
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
2024-11-26 ET
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
2024-11-05 14:59 ET
Dr. Reddy’s Q2 & H1FY25 Financial Results
2024-10-25 11:40 ET
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
2024-10-14 13:47 ET
Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month
2024-10-08 15:32 ET
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
2024-10-02 15:10 ET
Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
2024-08-20 18:42 ET
Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
2024-07-29 15:55 ET
Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
2024-07-27 13:51 ET
Dr. Reddy’s Q1FY25 Financial Results
2024-06-26 15:26 ET
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
2024-06-03 17:05 ET
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
2024-05-28 13:53 ET
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
2024-05-21 14:05 ET
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
2024-05-07 14:31 ET
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
2024-05-03 12:00 ET
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
2024-03-22 11:00 ET
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
2024-03-19 11:00 ET
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
2024-01-31 14:44 ET
Dr. Reddy’s Q3 & 9M FY24 Financial Results
2024-01-04 06:58 ET
Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International's Board of Directors
2024-01-03 11:00 ET
Dr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women’s Health and Dietary Supplements Portfolio of Brands
2023-12-14 12:49 ET
Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index
2023-12-06 12:00 ET
Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
2023-10-27 17:50 ET
Dr. Reddy’s Q2 FY24 Financial Results
2023-08-10 11:00 ET
Dr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.
2023-07-26 16:31 ET
Dr. Reddy’s Q1 FY24 Financial Results
2023-07-12 14:25 ET
Dr. Reddy’s Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
2023-06-05 11:00 ET
Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab
2023-05-10 15:43 ET
Dr. Reddy’s Q4 & FY23 Financial Results
2023-05-05 11:17 ET
Dr. Reddy's Laboratories Announces the Launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
2023-04-21 11:15 ET
Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.
2023-03-20 11:00 ET
Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddy’s Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302 for the Treatment of Neurodegenerative Diseases
2023-02-27 11:00 ET
Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio
2023-02-08 13:50 ET
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
2023-01-27 12:03 ET
Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
2023-01-20 11:30 ET
Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
2022-12-19 13:00 ET
Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
2022-10-11 11:57 ET
World Economic Forum Recognises Dr. Reddy’s Hyderabad Factory as Part of its Global Lighthouse Network
2022-09-07 17:28 ET
Dr. Reddy's Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity
2022-07-29 17:24 ET
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
2022-07-27 07:26 ET
Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
2022-07-22 10:17 ET
Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. Market
2022-07-08 15:48 ET
Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
2022-07-05 07:30 ET
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
2022-06-14 06:51 ET
Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market
2022-05-27 14:15 ET
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
2022-05-24 17:40 ET
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market
2022-04-20 16:41 ET
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market
2022-04-05 10:52 ET
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market
2022-04-01 12:00 ET
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
2022-02-09 14:17 ET
Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
2022-02-03 14:33 ET
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
2022-02-02 09:15 ET
Dr. Reddy’s Included in S&P Global’s Sustainability Yearbook for the 2nd Year and Bloomberg Gender-Equality Index for the 5th Year in a Row
2021-12-10 04:47 ET
Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market
2021-12-09 08:18 ET
Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market
2021-12-09 05:50 ET
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
2021-12-09 02:00 ET
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
2021-10-29 12:59 ET
Dr. Reddy's Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market
2021-10-15 17:40 ET
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
2021-09-09 12:30 ET
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
2021-09-04 05:11 ET
Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)
2021-09-02 04:12 ET
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market
2021-08-31 06:43 ET
Dr. Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market
2021-08-18 12:30 ET
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
2021-08-04 14:32 ET
Dr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL
2021-08-03 12:32 ET
Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market
2021-06-30 ET
Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F
2021-06-22 ET
Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market
2021-06-03 ET
Global Response Aid Reports Midyear Sales Results for COVID Drug
2021-05-13 ET
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
2021-05-12 ET
Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
2021-04-29 ET
Dr. Reddy's Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market
2021-04-13 ET
Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputnik V in India
2021-04-07 ET
Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market
2021-02-22 ET
Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market
2021-02-19 ET
Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V
2021-02-18 ET
Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market
2021-02-17 ET
Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market
2021-02-02 ET
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market
2021-01-29 ET
Dr. Reddy’s Q3 & 9M FY21 Financial Results

SEC forms

Show financial reports only

SEC form 6
2026-07-22 17:59 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:59 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 12:31 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 12:31 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 12:27 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-22 12:27 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-15 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-15 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-13 10:35 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-07-13 10:35 ET
Dr. Reddy's Laboratories Limited published news for 2026 q2
SEC form 6
2026-06-26 15:59 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-26 15:59 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 17:38 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 17:38 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-22 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-15 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-15 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-10 15:28 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-10 15:28 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-05 15:57 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-05 15:57 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-03 10:31 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-03 10:31 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-01 12:03 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-01 12:03 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-01 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-06-01 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-28 17:11 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-28 17:11 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-28 11:37 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-28 11:37 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-18 17:00 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-18 17:00 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-18 10:45 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-18 10:45 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-15 19:55 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-15 19:55 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:11 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:11 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 21:01 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 18:53 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 18:53 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 14:02 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 14:02 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 06:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-12 06:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-11 16:48 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-05-11 16:48 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-29 10:37 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-29 10:37 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-24 11:06 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-24 11:06 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-24 10:25 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-24 10:25 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-16 13:38 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-16 13:38 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-15 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-15 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-08 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-04-08 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2026 q1
SEC form 6
2026-03-26 11:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-26 11:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-24 15:16 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-24 15:16 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-23 14:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-23 14:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-23 11:04 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-23 11:04 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-17 14:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-17 14:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-13 16:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-13 16:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-12 17:00 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-12 17:00 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-12 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-12 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-11 13:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-11 13:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-06 12:45 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-06 12:45 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-05 16:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-03-05 16:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-27 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-27 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-24 15:51 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-24 15:51 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-18 16:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-18 16:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-17 11:32 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-17 11:32 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-12 14:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-12 14:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-10 12:54 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-10 12:54 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-02 12:39 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-02-02 12:39 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-28 11:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-28 11:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-26 11:05 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-26 11:05 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-22 11:37 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-22 11:37 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 12:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 12:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 12:28 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 12:28 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 12:28 ET
Dr. Reddy's Laboratories Limited reported for 2025 q4
SEC form 6
2026-01-21 12:28 ET
Dr. Reddy's Laboratories Limited reported for 2025 q4
SEC form 6
2026-01-21 12:28 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-21 11:22 ET
Dr. Reddy's Laboratories Limited reported for 2025 q4
SEC form 6
2026-01-21 11:22 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-15 11:09 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-15 11:09 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-12 11:08 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-12 11:08 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-09 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-09 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-02 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2026-01-02 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2025 q4
SEC form 6
2025-12-31 11:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-31 11:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-23 07:33 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-23 07:33 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-16 12:29 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-16 12:29 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-16 12:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-16 12:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-12 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-12 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-12 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-12 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-10 02:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-10 02:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-08 16:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-08 16:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-03 09:55 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-12-03 09:55 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-28 08:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-28 08:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-26 21:28 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-26 21:28 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-26 21:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-26 21:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-25 11:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-25 11:03 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-18 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-18 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-17 11:56 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-17 11:56 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-17 06:08 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-17 06:08 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-13 13:06 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-13 13:06 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-12 11:31 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-11-12 11:31 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-31 00:45 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-31 00:45 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-29 13:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-29 13:57 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-27 10:55 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-27 10:55 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-27 10:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-27 10:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 21:23 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited reported for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited reported for 2025 q3
SEC form 6
2025-10-24 19:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-24 17:21 ET
Dr. Reddy's Laboratories Limited reported for 2025 q3
SEC form 6
2025-10-24 17:21 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-21 15:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-21 15:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-14 10:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-10-14 10:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q3
SEC form 6
2025-09-22 15:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-22 15:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-22 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-22 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-18 21:47 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-18 21:47 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-16 13:13 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-16 13:13 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-15 11:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-15 11:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-15 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-15 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-11 14:53 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-11 14:53 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-08 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-08 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-04 17:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-04 17:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-02 11:53 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-02 11:53 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-02 11:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-09-02 11:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-29 10:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-29 10:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-26 13:17 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-26 13:17 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-21 10:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-21 10:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-13 10:40 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-13 10:40 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-11 12:29 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-11 12:29 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-08 10:42 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-08-08 10:42 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-30 10:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-30 10:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-30 10:43 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-30 10:43 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-26 00:51 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-26 00:51 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-25 10:58 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-25 10:58 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-25 10:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-25 10:52 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 18:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 18:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 18:37 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 18:37 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 10:59 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-24 10:59 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 18:30 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 18:30 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 18:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 18:25 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:33 ET
Dr. Reddy's Laboratories Limited reported for 2025 q2
SEC form 6
2025-07-23 17:33 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited reported for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-23 17:20 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-22 15:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-22 15:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-21 16:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-21 16:44 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-18 16:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-18 16:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-15 12:12 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-15 12:12 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-02 15:35 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-02 15:35 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-01 17:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-07-01 17:10 ET
Dr. Reddy's Laboratories Limited published news for 2025 q2
SEC form 6
2025-06-30 17:02 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-30 17:02 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-30 13:35 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-30 13:35 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-23 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-23 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-23 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-23 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-20 12:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-20 12:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-20 12:16 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-20 12:16 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-18 16:31 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-18 16:31 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-11 10:32 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-11 10:32 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-09 10:13 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-09 10:13 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 16:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 16:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 14:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 14:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 00:42 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-05 00:42 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-02 11:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-06-02 11:49 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-28 12:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-28 12:26 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-28 12:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-28 12:24 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-27 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-27 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-20 12:38 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-20 12:38 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-19 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-19 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-16 01:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-16 01:15 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-14 10:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-14 10:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-12 10:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited reported for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited reported for 2025 q1
SEC form 6
2025-05-09 17:14 ET
Dr. Reddy's Laboratories Limited reported for 2025 q1
SEC form 6
2025-05-09 16:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 16:19 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 16:04 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-05-09 16:04 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-25 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-25 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-16 13:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-16 13:27 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-14 17:33 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-14 17:33 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-07 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-04-07 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2025 q1
SEC form 6
2025-03-24 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-24 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-21 18:40 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-21 18:40 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-13 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-13 17:36 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-12 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-12 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-07 16:02 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-07 16:02 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-06 12:33 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-06 12:33 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-03 11:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-03-03 11:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-25 12:43 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-25 12:43 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-14 16:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-14 16:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-12 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-12 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-12 11:08 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-12 11:08 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-06 14:30 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-06 14:30 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-05 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-05 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 13:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 13:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 11:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-04 11:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-03 11:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-02-03 11:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-29 17:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-29 17:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-29 12:13 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-29 12:13 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-23 15:21 ET
Dr. Reddy's Laboratories Limited reported for 2024 q4
SEC form 6
2025-01-23 15:21 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-23 13:50 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-23 13:50 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-23 13:50 ET
Dr. Reddy's Laboratories Limited reported for 2024 q4
SEC form 6
2025-01-23 13:50 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-23 13:50 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-22 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2025-01-22 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q4
SEC form 6
2024-12-06 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-06 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-06 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-06 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-03 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-03 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-12-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-29 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-29 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-27 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-27 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-26 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-26 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-26 06:08 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-26 06:08 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-21 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-21 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-20 06:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-20 06:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-19 08:02 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-19 08:02 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-14 07:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-14 07:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-12 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-12 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-07 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-07 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-06 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-06 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-06 06:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-06 06:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-05 14:14 ET
Dr. Reddy's Laboratories Limited reported for 2024 q3
SEC form 6
2024-11-05 14:14 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-05 13:40 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-05 13:40 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-05 13:40 ET
Dr. Reddy's Laboratories Limited reported for 2024 q3
SEC form 6
2024-11-05 13:40 ET
Dr. Reddy's Laboratories Limited reported for 2024 q3
SEC form 6
2024-11-05 13:40 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-04 12:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-11-04 12:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-29 10:53 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-29 10:53 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-28 08:26 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-28 08:26 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-21 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-21 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-15 07:38 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-15 07:38 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-10 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-10 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-08 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-08 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-07 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-07 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-04 15:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-04 15:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-02 10:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-02 10:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-02 06:32 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-10-02 06:32 ET
Dr. Reddy's Laboratories Limited published news for 2024 q3
SEC form 6
2024-09-30 06:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-30 06:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-27 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-27 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-26 07:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-26 07:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-24 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-24 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-23 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-23 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-20 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-20 12:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-16 08:20 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-16 08:20 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-12 15:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-12 15:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-10 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-09-10 10:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 14:25 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 14:25 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 11:49 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 11:49 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 10:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 07:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 07:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 07:35 ET
Dr. Reddy's Laboratories Limited reported for 2024 q2
SEC form 6
2024-07-29 07:35 ET
Dr. Reddy's Laboratories Limited reported for 2024 q2
SEC form 6
2024-07-29 07:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 06:38 ET
Dr. Reddy's Laboratories Limited reported for 2024 q2
SEC form 6
2024-07-29 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-29 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-24 15:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-24 15:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-24 15:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-24 15:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-23 11:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-23 11:31 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-18 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-18 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-15 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-15 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-10 11:12 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-10 11:12 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-05 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-05 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-03 08:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-03 08:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-03 07:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-07-03 07:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q2
SEC form 6
2024-06-28 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-28 10:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-28 06:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-28 06:05 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-26 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-26 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-26 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-26 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-24 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-24 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-21 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-21 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-20 13:55 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-20 13:55 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-20 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-20 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-18 08:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-18 08:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-14 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-14 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-14 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-14 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-13 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-13 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-12 13:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-12 13:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 20
2024-06-12 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-10 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-10 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-07 14:45 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-07 14:45 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-07 10:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-07 10:39 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-05 08:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-05 08:35 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-04 08:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-04 08:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-03 17:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-03 17:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-03 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-06-03 06:07 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-31 07:27 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-31 07:27 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-30 11:20 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-30 11:20 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-30 11:17 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-30 11:17 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-29 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-29 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-28 07:57 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-28 07:57 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-08 12:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-08 12:23 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-08 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-08 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited reported for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited reported for 2024 q1
SEC form 6
2024-05-07 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-07 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-03 08:14 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-05-03 08:14 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-30 14:44 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-30 14:44 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-25 07:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-25 07:10 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-25 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-25 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-23 13:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-23 13:24 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-22 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-22 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-18 10:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-18 10:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-15 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-15 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-10 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-10 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-05 09:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-05 09:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-03-27 08:37 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-27 08:37 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-19 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-19 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-15 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-15 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-13 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-13 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-12 14:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-12 14:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-04 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-04 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-01 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-01 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-26 06:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-26 06:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-23 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-23 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-21 08:43 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-21 08:43 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-20 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-20 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-19 10:00 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-19 10:00 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 13:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 13:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-10 08:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-10 08:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-08 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-08 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-03 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-03 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2023-12-29 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-21 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-21 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-15 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-15 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-12 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-12 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-11 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-11 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-08 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-08 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-06 11:30 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-06 11:30 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-01 07:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-01 07:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-11-28 08:59 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-11-28 08:59 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-27 13:19 ET
Dr. Reddy's Laboratories Limited reported for 2023 q3
SEC form 6
2023-10-26 09:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-16 15:44 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-12 11:47 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-10 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-09-28 13:29 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-28 13:23 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-22 07:55 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-19 14:38 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-19 14:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-18 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-07 07:27 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-06 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-05 21:49 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-08-29 07:15 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-27 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-27 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-26 18:11 ET
Dr. Reddy's Laboratories Limited reported for 2023 q2
SEC form 6
2023-07-26 14:56 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-21 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-19 11:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-18 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-17 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-12 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-06 09:07 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-03 07:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-06-23 07:47 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-23 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-20 06:52 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-20 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-14 09:26 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-13 16:06 ET
Dr. Reddy's Laboratories Limited reported for 2023 q1
SEC form 20
2023-06-13 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-12 21:54 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-05 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-01 07:50 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-22 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-16 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-15 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-12 06:13 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-10 17:20 ET
Dr. Reddy's Laboratories Limited reported for 2023 q1
SEC form 6
2023-05-10 12:02 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-04-07 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-03-24 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-24 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-21 08:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-16 13:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-13 08:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-28 12:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-27 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-16 21:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-08 20:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-03 11:47 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-30 10:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-27 09:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-26 18:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-26 11:51 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-25 14:51 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-25 14:48 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-25 13:38 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-20 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-13 07:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-13 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-06 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2022-12-29 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-27 08:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-27 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-19 07:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-19 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-16 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-06 21:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-28 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-22 14:07 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-16 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-03 13:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-02 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-31 07:43 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-31 06:13 ET
Dr. Reddy's Laboratories Limited reported for 2022 q3
SEC form 6
2022-10-28 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-28 14:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-24 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-13 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-11 13:32 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-09-29 10:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-27 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-23 07:02 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-20 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-19 06:51 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-12 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-08 06:13 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-07 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-26 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-25 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-08 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-03 09:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 14:49 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 12:46 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 21:56 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 15:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 14:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-27 08:10 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-22 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-13 21:50 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-12 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-08 13:52 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-07 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-07 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-06-30 06:30 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-28 08:51 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-27 15:02 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 20
2022-06-27 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-24 10:20 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-22 07:13 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-21 06:44 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-21 06:37 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-14 13:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-13 13:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-09 13:40 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-03 14:29 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-02 21:53 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-31 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-24 15:47 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-24 13:31 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-20 21:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-19 21:52 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-19 16:28 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-11 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-25 16:06 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-22 14:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-20 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-11 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-08 12:06 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-07 13:18 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-05 06:56 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-01 13:36 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-03-29 09:33 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-03-17 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-03-17 08:10 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-28 12:31 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-25 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-25 06:43 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-22 06:55 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-14 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-11 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 14:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-07 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-03 07:50 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-02 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-01 14:01 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-31 09:52 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 11:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-18 13:54 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-18 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-10 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-07 13:10 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2021-12-28 12:14 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-20 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-10 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-10 06:44 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-09 07:21 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-08 06:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-08 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-05 14:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-01 06:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-01 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-29 15:03 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-19 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-18 06:37 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-15 12:33 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-07 09:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-09-27 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-22 10:47 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-10 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-07 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-07 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-03 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-02 08:07 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-31 07:53 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-10 10:59 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-04 14:59 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-03 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-03 08:16 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-02 14:42 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-29 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 12:42 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 11:58 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-07 08:55 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-06 06:29 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-02 14:38 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-01 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-06-30 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 20
2021-06-30 00:00 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-29 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-28 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-28 07:09 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-24 10:48 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-22 09:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-15 14:36 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-04 13:43 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-24 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-21 08:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-19 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-17 06:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-14 15:13 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-14 14:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-12 08:46 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-10 07:07 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-03 09:20 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-29 14:09 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-23 13:30 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-13 06:54 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-07 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-01 14:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-01 07:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-03-29 11:43 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-22 09:55 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-10 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-01 09:58 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-22 07:14 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-19 08:25 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-18 08:08 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-17 06:30 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-03 11:32 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-02 07:15 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-01 08:33 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-29 08:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-27 09:07 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-15 16:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-11 13:01 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-11 08:47 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-08 12:50 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2020-12-29 13:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-28 13:04 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-22 07:36 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-09 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-08 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-08 09:53 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-30 07:11 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-19 10:03 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-13 10:26 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-30 08:20 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-29 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-29 07:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-28 12:57 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-28 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-22 09:57 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-20 14:54 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-19 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-13 12:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-05 13:19 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-05 13:12 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-01 07:52 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3